None
Quote | AbbVie Inc. (NYSE:ABBV)
Last: | $161.52 |
---|---|
Change Percent: | 0.02% |
Open: | $159.59 |
Close: | $161.52 |
High: | $161.55 |
Low: | $158.56 |
Volume: | 6,215,259 |
Last Trade Date Time: | 04/29/2024 03:00:00 am |
News | AbbVie Inc. (NYSE:ABBV)
2024-04-29 15:08:53 ET Summary AbbVie Inc.'s shares dropped last week due to concerns about the erosion of Humira and despite the company beating revenue and EPS expectations. Humira's global sales fell 36% YoY, but AbbVie's other growth products performed well, leading to overall...
2024-04-29 11:00:06 ET Evan Seigerman from BMO Capital issued a price target of $180.00 for ABBV on 2024-04-29 09:49:00. The adjusted price target was set to $180.00. At the time of the announcement, ABBV was trading at $158.5841. The overall price target consensus is at...
Message Board Posts | AbbVie Inc. (NYSE:ABBV)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ABBV News Article - AbbVie Stock Plunged: Should You Buy the Dip? | whytestocks | investorshangout | 05/01/2023 7:35:47 PM |
$ABBV reports 1Q23 resultsraises non-GAAP EPS guidance: | DewDiligence | investorshub | 04/27/2023 12:00:28 PM |
$ABBVFDA expands Qulipta label_to prevention of chronic migraine: | DewDiligence | investorshub | 04/18/2023 6:23:32 PM |
Skyrizi phase-3 in UC hits all endpoints: | DewDiligence | investorshub | 03/23/2023 2:02:00 PM |
$ABBV advances Rinvoq to phase-3 in lupus: | DewDiligence | investorshub | 03/23/2023 2:00:38 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-04-29 11:00:06 ET Evan Seigerman from BMO Capital issued a price target of $180.00 for ABBV on 2024-04-29 09:49:00. The adjusted price target was set to $180.00. At the time of the announcement, ABBV was trading at $158.5841. The overall price target consensus is at...
Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. As we look ahead to the unfolding week, it r...
2024-04-28 04:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...